|
|
|
|
PPD hit by higher number of cancellations in Q4
US contract research organisation (CRO) PPD reported a higher than anticipated number of cancellations in Q4, bringing to a close 12 months that saw operating income fall 46 per cent to $192m.The firm, which released its full 2009 results late yesterday,...
|
|
|
CRL's 2009 preclinical sales slide; but 2010 bookings up
Related topics: Clinical evolution, Preclinical Research, Preclinical Falling preclinical demand may have dominated Charles River Laboratories (CRL) performance in 2009, but stagnant sales from its research models business also failed to impress.Revenues...
|
|
|
People on the move: pharma outsourcing jobs
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including a new management team at a NextPharma site and appointments at Quintiles.Quintiles has bolstered its consulting group, appointing Bill Truhe as...
|
|
|
Gorbec opening analytical laboratory in China
Gorbec Pharmaceutical Services is opening a GMP compliant analytical laboratory in Yantai, China to improve the service it offers to US-based clients and expand its presence in Asia.The company plans to develop and submit more new drug applications (NDA) in...
|
|
|
Phase Forward says ICRS a must for data management market
Integrated solutions are the future of trial data management according to Phase Forward as growth of the electronic data capture (EDC) market begins to slow.The US firm said: It will be increasingly important for vendors to deliver a true end-to-end...
|
|
|
MENA emerging as trial destination says ClinTec CEO
Interview of Dr Rabinder Buttar CEO, ClinTec International Improving healthcare infrastructure across the region and a large treatment-nave patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials...
|
|
|
TTP launches contract screening service
TTP LabTech has launched a contract screening service to assist various aspects of clients drug development programmes, from target identification through to preclinical toxicology.Companies outsourcing to TTP will benefit from its knowledge of the...
|
|
|
Onyx invests in solid-state chemistry offering
UK CRO Onyx Scientific says that new solid state chemistry service will meet growing demand of drug industry squeezed by escalating R&D costs.The contract research organisation (CRO) has installed x-ray powder diffraction and Raman spectroscopy at its R...
|
|
|
Galapagos buys Argenta to strengthen discovery services
Belgium-based Galapagos NV has acquired Argenta Discovery for 16.5m ($23.1m), creating a drug discovery service company with 390 employees and estimated revenues of 70m.The acquisition creates a true powerhouse in the drug discovery services market,...
|
|
|
Onyx invests in solid-state chemistry offering
UK CRO Onyx Scientific says that new solid state chemistry service will meet growing demand of drug industry squeezed by escalating R&D costs.The contract research organisation (CRO) has installed x-ray powder diffraction and Raman spectroscopy at its R...
|
